Inventor · disambiguated record
David Miller
Also filed as: MILLER DAVID · MILLER DAVID J · MILLER DAVID JOHN
32 granted patents·18 pending applications·78 citations·filing 2000–2024
95Inventor score
Files withINFLAZOME LTD31TAKEDA PHARMACEUTICALS CO4FARNABY WILLIAM3SHOWELL GRAHAM ANDREW3UNIV QUEENSLAND2
Top patents by PatentIndex Score
50 records- 0191US11981667B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2022·Granted May 14, 2024·1 cites·8 claims
- 0290US11370776B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jun 28, 2022·6 cites·19 claims
- 0388US6645973B1Spiro(2h-1-benzopyran-2,4-piperidine)derivatives as glycine transport inhibitorsAKZO NOBEL·Filed 2000·Granted Nov 11, 2003·38 cites·7 claims
- 0484US11129828B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0583US11465992B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 11, 2022·1 cites·37 claims
- 0681US11613542B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 28, 2023·2 cites·32 claims
- 0780US11834433B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 5, 2023·2 cites·19 claims
- 0880US11542255B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jan 3, 2023·2 cites·24 claims
- 0980US11518739B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Dec 6, 2022·2 cites·22 claims
- 1080US9931340B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACUETICAL COMPANY LTD·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 1180US9290456B2Pyridazinone compounds and their use as DAAO inhibitorsFARNABY WILLIAM·Filed 2012·Granted Mar 22, 2016·4 cites·22 claims
- 1279US11858922B2Sulfonylureas and related compounds and use of sameUNIV QUEENSLAND·Filed 2017·Granted Jan 2, 2024·2 cites·36 claims
- 1379US11623922B2CompoundsINFLAZOME LTD·Filed 2018·Granted Apr 11, 2023·1 cites·16 claims
- 1479US9180122B25- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and painFARNABY WILLIAM·Filed 2012·Granted Nov 10, 2015·6 cites·28 claims
- 1579US2025115591A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 1678US12186313B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 7, 2025·0 cites·10 claims
- 1777US10463663B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 5, 2019·1 cites·16 claims
- 1876US11926600B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 12, 2024·1 cites·12 claims
- 1975US2025019355A1CompoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 2068US9750748B2Pyridazinones as DAAO enzyme inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·1 cites·18 claims
- 2165US7507824B2Spiro(2H-1benzopyran-2,4′-piperidine) derivates as glycine transport inhibitorsORGANON NV·Filed 2003·Granted Mar 24, 2009·2 cites·5 claims
- 2264US2021332020A1Phenylsulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 2361US10085986B2Pyrimidinone compounds and their useCOCKCROFT XIAO LING FAN·Filed 2012·Granted Oct 2, 2018·1 cites·12 claims
- 2457US2013052281A1Novel compoundsFARNABY WILLIAM·Filed 2012·Application pending·0 cites
- 2552US12187702B2Sulfonamideurea compoundsINFLAZOME LTD·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 2652US11884645B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jan 30, 2024·0 cites·20 claims
- 2752US2022389031A1Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2851US12221434B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Feb 11, 2025·0 cites·19 claims
- 2951US2010152200A1Alphavirus inhibitors and uses thereofUNIV MICHIGAN·Filed 2009·Application pending·0 cites
- 3050US12168653B2Sulfonamide derivates as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Dec 17, 2024·0 cites·18 claims
- 3150US11530200B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 20, 2022·0 cites·18 claims
- 3250US2023121952A1CompoundsINFLAZOME LTD·Filed 2021·Application pending·0 cites
- 3348US2022289766A1Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 3447US11905252B2CompoundsINFLAZOME LTD·Filed 2019·Granted Feb 20, 2024·0 cites·22 claims
- 3547US11840543B2Compounds and usesUNIV QUEENSLAND·Filed 2017·Granted Dec 12, 2023·0 cites·9 claims
- 3647US2021147349A1Phenylsulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3746US11773058B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 3, 2023·0 cites·20 claims
- 3846US2022289692A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 3945US2022106289A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 4044US12030879B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jul 9, 2024·0 cites·23 claims
- 4143US12012392B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Jun 18, 2024·0 cites·20 claims
- 4243US2020399242A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 4342US2021122739A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 4441US2020361895A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 4540US8846684B2Arbovirus inhibitors and uses thereofLARSEN SCOTT·Filed 2012·Granted Sep 30, 2014·0 cites·9 claims
- 4640US2009291915A1Silicon Compounds and Their UseSHOWELL GRAHAM ANDREW·Filed 2001·Application pending·0 cites
- 4739US2021261512A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 4838US2009209522A1Heterocyclic Non-Peptide GNRH AntagonistsSHOWELL GRAHAM ANDREW·Filed 2006·Application pending·0 cites
- 4932US2008261918A1Silicon Compounds and Their UseSHOWELL GRAHAM ANDREW·Filed 2003·Application pending·0 cites
- 5029US7407649B2Silicon compounds and their usePARADIGM THERAPEUTICS LTD·Filed 2004·Granted Aug 5, 2008·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when David Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →